Abstract
Chemotherapy in pulmonary tuberculosis, has undergone with the passing of years great changes because of the discovery of new antibiotics, and also because of a more precise identification of their effectiveness in terms of ability and speed in sputum conversion and to the ability to induce recovery and avoid relapses. Therefore in the anti-tubercular therapy we must consider the following points:
-
Effectiveness of drugs
-
Route of administration
-
Recovery time
-
Clinical and bacteriological relapses
-
Toxicity
-
Cost/benefit ratio
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Binda, G., Domenichini, E., Gottardi, A., Orlandi, B., Ortelli, E., Pacini, B., Fowst, G. 1971. Rifampicin, a general review. Arzneim — Forsch. 21, 1907–1977.
Blasi, A., Donatelli, L., Zanussi, C. 1978. Rifampicina 315–330, Ed. Minerva Medica.
Blasi, A., Nitti, V., Delle Veneri, F., Virgilio, R., Marsico, A. S. 1973. A controlled clinical evaluation of 3 intermittent chemotherapy regimens employing low dosage schedules of rifampicin in the treatment of newly diagnosed cases of pulmonary tuberculosis. XXII Int. Tuberc. Conf. Tokyo, 20–29.Chen. Girling Bull. UITC, 1981, 56, 157. (Reported by Fox).
Crofton, J. Bull UITC v.55, September-December, 1980.
Grumbach, F., Canetti, G., Le Lirzin, M. 1969. Rifampicin in daily and intermittent treatment of experimental neurine tuberculosis, emphasis on late results. Tubercle Lond ., 50 280.
Gyselen, A., Casemans, J., Vandenbergh, E., Laquet, L. M., Verbist, L. 1971. Effets secondaires de la chemiotherapie anti tuberculeuse: douze annees d’experience sanatoriale. XXI Int. Tuberc. Coference, Moscow. Excepta medica 74.
Horne, N. W. 1960. Prednisolone in treatment of pulmonary tuberculosis: a controlled trial. Final report to the Research Committee of the Tuberculosis Society of Scotland. Brit. Med. J., 2, 5215, 1751–1756.
Johnson, J. R., Taylor, B. C., Morrissey, J. F., Jenne, J. W., Macdonald, F. M. 1965. Corticosteroides in pulmonary tuberculosis. Am. Rev. Resp. Dis., 92, 3, 376–391.
Lucchesi, M. 1971. La terapia intermittente antitubercolare basi sperimentali. Annali Medici de Sondalo, 19, 125.
Mitchison, D. A., Dickinson, J. M. 1978. Mecanisme de la bactericidie dans la chimioterapie de courte duree. Bull. UITC, v. 53, 4, 270–275.
Report Medical Research Council by their Tuberculosis chemotherapy trials Committee. 1962. Long term chemotherapy in the treatment of chronic pulmonary tuberculosis with ????. Tubercle, 43, 201
Spina, G. 1970. Intolleranza nella terapia della tubercolosi polmonare trattata con Rifampicina. Simposio Nazionale sulla rifampicina. Roma Settembre, (Simposi Lepetit).
Spina, G. 1978. Rifampicina, 229–230. Ed. Minerva Medica .
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Springer Science+Business Media New York
About this chapter
Cite this chapter
Spina, G. (1984). Treatment of Pulmonary Tuberculosis. In: Cumming, G., Bonsignore, G. (eds) Drugs and the Lung. Ettore Majorana International Science Series, vol 14. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-1269-8_9
Download citation
DOI: https://doi.org/10.1007/978-1-4757-1269-8_9
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-1271-1
Online ISBN: 978-1-4757-1269-8
eBook Packages: Springer Book Archive